1. Molecular imaging for the characterization of breast tumors
- Author
-
Barbara Füger, Peter Brader, Pascal A. T. Baltzer, Thomas H. Helbich, Oshaani Abeyakoon, Hubert Bickel, Georg Wengert, Katja Pinker, Heinrich Magometschnigg, and Stephan H. Polanec
- Subjects
Technetium Tc 99m Sestamibi ,In vivo magnetic resonance spectroscopy ,Fluorine Radioisotopes ,Pathology ,medicine.medical_specialty ,Breast imaging ,Proton Magnetic Resonance Spectroscopy ,Breast Neoplasms ,Multimodal Imaging ,Sensitivity and Specificity ,Breast cancer ,Fluorodeoxyglucose F18 ,Biomarkers, Tumor ,Humans ,Medicine ,Pharmacology (medical) ,Estradiol ,business.industry ,Carcinoma ,medicine.disease ,Magnetic Resonance Imaging ,Response to treatment ,Molecular Imaging ,Characterization (materials science) ,Oncology ,Tumor morphology ,Positron-Emission Tomography ,Female ,Cancer development ,Radiopharmaceuticals ,Molecular imaging ,business ,Mammography - Abstract
Recently, molecular imaging, using various techniques, has been assessed for breast imaging. Molecular imaging aims to quantify and visualize biological, physiological, and pathological processes at the cellular and molecular levels to further elucidate the development and progression of breast cancer and the response to treatment. Molecular imaging enables the depiction of tumor morphology, as well as the assessment of functional and metabolic processes involved in cancer development at different levels. To date, molecular imaging techniques comprise both nuclear medicine and radiological techniques. This review aims to summarize the current and emerging functional and metabolic techniques for the molecular imaging of breast tumors.
- Published
- 2014